Invuity, Inc. is a San Francisco-based biotechnology and healthcare company founded in 2004, with a focus on pioneering advanced lighting and visualization for minimally invasive surgeries. The company's flagship products include the BriteField Port System, designed to enhance illumination and visibility during minimally invasive procedures, and the BriteField McCulloch retractor, which enables physicians to maintain visual clarity using traditional surgical methods. In February 2015, Invuity secured a significant $22.90MPrivate Equity Round investment from prominent investors including Kleiner Perkins, InterWest Partners, Wellington Management, HealthCare Royalty Partners, and Valence Life Sciences. The company's innovative approach to addressing the needs of minimally invasive surgery positions it at the forefront of the industry, with promising potential for growth and impact. With its robust product portfolio and strong investor support, Invuity is well-positioned to continue making strides in advancing surgical visualization and lighting technology.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Private Equity Round | $22.90M | 5 | 13 Feb 2015 | |
Series E | $36.00M | 5 | 04 Mar 2014 | |
Series D | $25.00M | 4 | Wexford Capital | 14 Jun 2012 |
Venture Round | $2.00M | 5 | Wexford Capital | 09 Jan 2012 |
Series C | $13.20M | 2 | 01 Jul 2010 |
No recent news or press coverage available for Invuity.